IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Pioneering, LLC

Q1 2017 Holdings

Filed 2017-05-10 | 9 holdings | $56.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Agios Pharmaceuticals Inc(AGIO)COM00847X104$56.4M965,36999.4%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$142.9K12,682,8760.3%
Syros Pharmaceuticals IncCOM87184Q107$76.6K4,806,6560.1%
Editas Medicine Inc(EDIT)COM28106W103$75.4K3,376,1840.1%
Selecta Biosciences Inc(SELBUSD)COM816212104$11.8K826,8620.0%
T2 Biosystems IncCOM89853L104$10.3K1,950,5830.0%
Eleven Biotherapeutics IncCOM286221106$2.9K1,324,0180.0%